PEN Penumbra Earnings and EPS analysis

Relative Growth: Rel. Growth: 72

Relative Strength: Rel. Strength: 58

Relative Valuation: Rel. Valuation: 38

Relative Profitability: Rel. Profitability: 90

EPS in 2026 (TTM): $4.38

Last Report Period Date: Mar 31, 2026

Currently, PEN's trailing twelve months (TTM) EPS stands at $4.38, according to the most recent financial reports. In 2025, PEN reported a per-share earnings of $4.57, which represents an increase compared to the EPS of $0.36 recorded in 2024. PEN recorded an EPS of $0.83 for the quarterly period ending on Mar 31, 2026.

PEN earnings history

Historical annual and quarterly earnings per share (EPS) data for Penumbra

EPS (TTM)

$4.38

EPS Growth YoY (Quarterly)

-18.6%

EPS (Quarterly)

$0.83

EPS Growth (Quarterly)

-31.4%

In 2025, Penumbra's EPS was $4.57, an increase of 1,169.4% from $0.36 in 2024. For the quarter ending Mar 31, 2026, the EPS was $0.83, reflecting a 18.6% decline compared to the same quarter a year earlier. The trailing twelve months (TTM) EPS as of March 2026 is $4.38. In 2024, the annual EPS was $0.36, showing a decrease of 84.8% compared to 2023.

PEN earnings chart

PEN EPS growth history

Earnings per share growth rates over time

EPS Growth YoY (Quarterly)

-18.6%

EPS growth YoY

1,169.4%

EPS growth 3Y avg

N/A

EPS growth 5Y avg

N/A

Over the past 12 months, Penumbra has recorded an earnings per share growth of -18.6% (YoY, quarterly). When assessed over a ten-year period, PEN's average EPS annual growth was 48.1%.

PEN Earnings Waterfall

Breakdown of revenue, profit and net income for Penumbra

PEN Earnings vs Peers

What are the earnings of PEN compared to its peers

Stock name	Price to Earnings	EPS grwoth 1Y	EPS grwoth 3Y	EPS grwoth 5Y
PEN Penumbra Inc	72.77	1,169.4%	N/A	N/A
OFIX Orthofix Medical Inc	N/A	29.4%	N/A	N/A

All data is based on quarterly TTM periods, unless otherwise specified.